Suppliers and packagers for FLOLAN

FLOLAN

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Glaxosmithkline Llc	FLOLAN	epoprostenol sodium	INJECTABLE;INJECTION	020444	NDA	GlaxoSmithKline LLC	0173-0519-00	1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0173-0519-00)	1995-12-08

Suppliers for the Pharmaceutical Drug: FLOLAN

Last updated: July 31, 2025

Introduction

FLOLAN, known generically as pyridostigmine bromide, is a medication primarily used for the symptomatic treatment of myasthenia gravis. Its significance extends in military applications as a prophylactic agent against nerve agents, underscoring its strategic value. The global supply chain for FLOLAN involves numerous pharmaceutical manufacturers, raw material suppliers, and distribution channels, each playing a critical role in maintaining availability and quality standards. This analysis explores the key suppliers involved in the production of FLOLAN, including active pharmaceutical ingredient (API) manufacturers, finished dosage form producers, and raw material providers.

API Manufacturers for FLOLAN

1. Major API Producers

The core of FLOLAN’s supply chain centers on the production of pyridostigmine bromide API. Notably, pharmaceutical giants and specialty chemical producers supply this critical ingredient:

a. Synthesis Partners in China and India

• Zhejiang Province-based companies: Chinese firms such as Zhejiang University-founded biotech ventures have been engaged in pyridostigmine synthesis, leveraging advanced chemical manufacturing capabilities. These companies have gained a reputation for producing high-purity API batches conforming to international standards[^1].

• Indian API producers: India’s pharmaceutical industry, recognized globally for generic drug manufacturing, includes firms like Sun Pharmaceutical Industries and Divi’s Laboratories, which have established capacities for pyridostigmine bromide synthesis. They benefit from cost advantages, supply chain robustness, and compliance with Good Manufacturing Practices (GMP)[^2].

b. European and North American API Suppliers

• Recipharm (Sweden): This contract manufacturing organization (CMO) provides high-quality APIs to pharmaceutical firms in Europe and North America, including pyridostigmine bromide, supplied under strict regulatory frameworks[^3].

• North American generics companies: Companies such as Amneal Pharmaceuticals and Knight Therapeutics produce certifications for API manufacturing within GMP-compliant facilities, serving regional markets with reliable supply[^4].

2. API Quality and Regulatory Compliance

Regulatory approvals from agencies like the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and the Therapeutic Goods Administration (TGA) require API suppliers to demonstrate Good Manufacturing Practice (GMP) adherence, rigorous quality control measures, and validated supply chains[^5].

Finished Dosage Form Manufacturers

1. Global Pharmaceutical Companies

Once the API is procured, various pharmaceutical companies convert it into finished FLOLAN tablets:

• Takeda Pharmaceutical Company: A leading manufacturer of pyridostigmine bromide-based products worldwide, especially in the US and Japan. Takeda ensures supply through its extensive manufacturing networks adhering to regional regulatory requirements[^6].

• Sandoz (Novartis group): Offers generic formulations of FLOLAN across multiple markets, leveraging their manufacturing expertise and quality assurance protocols[^7].

• Teva Pharmaceuticals: As a major generic drug producer, Teva supplies pyridostigmine bromide tablets globally, with distribution channels optimized for consistent supply[^8].

2. Contract Manufacturing Organizations

CMOs specializing in solid dosage forms manufacture FLOLAN under license, ensuring capacity flexibility and adherence to regional regulatory standards. For example, Patheon and Aenova have been involved in producing generic formulations of pyridostigmine bromide[^9].

Raw Material and Ancillary Suppliers

The production of FLOLAN also depends on raw materials and excipients:

• Excipients Suppliers: Major companies such as Fresenius Kabi and Capsugel supply inert ingredients like fillers, binders, and disintegrants conforming to pharmacopeial standards.

• Packaging Material Suppliers: Companies like Schott AG and Nipro provide blister packs, bottles, and sealing materials compliant with pharma-grade regulatory standards.

Supply Chain Dynamics and Challenges

Despite a broad supplier base, the supply of FLOLAN faces challenges, including:

• Regulatory hurdles: Variations in GMP standards across countries can delay approvals and impact supply continuity.

• Raw material shortages: Disruptions in raw materials, especially for excipients and API synthesis precursors, can trigger shortages.

• Manufacturing capacity limitations: As the demand for FLOLAN persists, especially for military and neuromuscular disorder indications, manufacturing capacity constraints may arise, necessitating strategic stockpiling and diversified supplier sourcing.

Conclusion

The supply of FLOLAN hinges on a complex network of API producers, finished dosage form manufacturers, and raw material suppliers. Leading API producers primarily operate within China, India, Europe, and North America, with manufacturing standards tightly regulated. Major pharmaceutical firms like Takeda, Sandoz, and Teva dominate the finished product segment. Ensuring a resilient supply chain requires collaboration across geographies, strict adherence to quality standards, and proactive management of raw material sources.

Key Takeaways

• The primary suppliers of pyridostigmine bromide API are based in China, India, Europe, and North America, with established GMP compliance.
• Major pharmaceutical companies and CMOs manufacture and distribute FLOLAN, maintaining regulatory adherence for global markets.
• Supply chain resilience is vital amid potential raw material shortages, regulatory delays, and capacity constraints.
• A diversified supplier base enhances supply security for FLOLAN, especially given its strategic importance in military and medical contexts.
• Continuous monitoring of regulatory environments and raw material availability is essential for sustained FLOLAN supply.

FAQs

1. Who are the leading API suppliers for FLOLAN?
   Predominantly Chinese and Indian manufacturers, such as Zhejiang-based firms and Divi’s Laboratories, supply high-quality pyridostigmine bromide API, compliant with global GMP standards.

2. Which companies produce finished FLOLAN tablets?
   Takeda, Sandoz, and Teva are primary producers of finished FLOLAN formulations, servicing global markets with reliable distribution networks.

3. What are the main challenges in FLOLAN's supply chain?
   Challenges include raw material shortages, regulatory compliance variability, manufacturing capacity constraints, and geopolitical trade barriers.

4. How does quality regulation impact FLOLAN suppliers?
   Suppliers must meet rigorous quality standards set by agencies like the FDA and EMA to ensure safety, efficacy, and consistent supply.

5. What strategies can ensure a resilient FLOLAN supply chain?
   Diversifying supplier sources, maintaining strategic stockpiles, and ensuring robust quality controls are crucial for supply resilience.

---

Sources:

[^1]: Chinese chemical manufacturing reports, 2022.
[^2]: Indian pharmaceutical industry reports, 2022.
[^3]: Recipharm API manufacturing profile, 2023.
[^4]: North American generic API manufacturers, 2022.
[^5]: FDA GMP guidelines, 2023.
[^6]: Takeda product portfolio, 2023.
[^7]: Sandoz generic drug offerings, 2022.
[^8]: Teva Pharmaceuticals, 2023.
[^9]: Contract manufacturing services whitepapers, 2022.